• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

股腘动脉斑块旋切术:随机对照试验的系统评价和荟萃分析

Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials.

作者信息

Diamantopoulos A, Katsanos K

机构信息

Department of Interventional Radiology Guy's and St. Thomas' NHS Foundation Trust London, UK -

出版信息

J Cardiovasc Surg (Torino). 2014 Oct;55(5):655-65. Epub 2014 Jul 10.

PMID:25008063
Abstract

A systematic review was performed to provide a qualitative analysis and quantitative data synthesis of randomized controlled trials (RCTs) assessing debulking atherectomy versus balloon angioplasty for treatment of femoropopliteal artery occlusive disease. PubMed (MEDLINE), EMBASE, AMED, Scopus, online content and meeting abstracts were searched in May 2014 for eligible RCTs following the PRISMA selection process. Risk of bias was assessed using the Cochrane Collaboration's tool. Pooled risks were calculated with a random effects model to account for clinical and conceptual heterogeneity. Sensitivity analysis was employed to test the robustness of the results. Six RCTs comprising 287 patients (328 lesions) treated with either debulking atherectomy or balloon angioplasty for femoropopliteal artery disease were analyzed and synthesized. Technical success was similar between the atherectomy and the angioplasty group (93.6% vs. 96.2%, RR: 0.99. 95%CI: 0.95-1.03, P=0.57, I(2)=0%). Need for bail-out stenting and distal arterial embolization were largely similar between atherectomy and balloon angioplasty alone. After a median follow-up of 9 months the 2 groups showed similar primary patency (RR: 0.90, 95%CI: 0.56-1.46, P=0.68, I(2)=69%). Only 2 low-quality studies reported amputation and mortality rates, both of which were found significantly less in the atherectomy arms. Analysis of a limited body of low quality evidence with high risk of bias showed that debulking atherectomy of the femoropopliteal artery does not seem to confer any procedural advantage or improvement of clinical outcomes over balloon angioplasty alone.

摘要

进行了一项系统评价,以对评估斑块旋切术与球囊血管成形术治疗股腘动脉闭塞性疾病的随机对照试验(RCT)进行定性分析和定量数据综合。2014年5月,按照PRISMA选择流程在PubMed(MEDLINE)、EMBASE、AMED、Scopus、在线内容和会议摘要中检索符合条件的RCT。使用Cochrane协作工具评估偏倚风险。采用随机效应模型计算合并风险,以考虑临床和概念上的异质性。进行敏感性分析以检验结果的稳健性。分析并综合了6项RCT,共287例患者(328处病变),这些患者接受了斑块旋切术或球囊血管成形术治疗股腘动脉疾病。旋切术组和血管成形术组的技术成功率相似(93.6%对96.2%,RR:0.99,95%CI:0.95 - 1.03,P = 0.57,I² = 0%)。单纯旋切术和球囊血管成形术之间,补救性支架置入需求和远端动脉栓塞情况基本相似。中位随访9个月后,两组的主要通畅率相似(RR:0.90,95%CI:0.56 - 1.46,P = 0.68,I² = 69%)。只有2项低质量研究报告了截肢率和死亡率,两者在旋切术组均显著更低。对一组存在高偏倚风险的有限低质量证据的分析表明,股腘动脉斑块旋切术与单纯球囊血管成形术相比,似乎并未带来任何手术优势或改善临床结局。

相似文献

1
Atherectomy of the femoropopliteal artery: a systematic review and meta-analysis of randomized controlled trials.股腘动脉斑块旋切术:随机对照试验的系统评价和荟萃分析
J Cardiovasc Surg (Torino). 2014 Oct;55(5):655-65. Epub 2014 Jul 10.
2
A Systematic Review and Meta-analysis of Atherectomy Plus Balloon Angioplasty Versus Balloon Angioplasty Alone for Infrapopliteal Arterial Disease.腘下动脉疾病:斑块旋切术联合球囊血管成形术与单纯球囊血管成形术的系统评价和荟萃分析
J Endovasc Ther. 2023 Nov 7:15266028231209236. doi: 10.1177/15266028231209236.
3
Systematic Review and Meta-analysis of Randomized Controlled Trials of Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Arteries: Role of Paclitaxel Dose and Bioavailability.紫杉醇涂层球囊血管成形术治疗股腘动脉随机对照试验的系统评价和荟萃分析:紫杉醇剂量和生物利用度的作用
J Endovasc Ther. 2016 Apr;23(2):356-70. doi: 10.1177/1526602815626557. Epub 2016 Jan 28.
4
The efficacy of atherectomy combined with percutaneous transluminal angioplasty (PTA)/drug-coated balloon (DCB) compared with PTA/DCB for infrapopliteal arterial diseases: A systematic review and meta-analysis.与经皮腔内血管成形术(PTA)/药物涂层球囊(DCB)相比,旋切术联合PTA/DCB治疗腘动脉以下动脉疾病的疗效:一项系统评价和荟萃分析。
Vascular. 2025 Jun;33(3):654-664. doi: 10.1177/17085381241252861. Epub 2024 May 8.
5
Atherectomy for peripheral arterial disease.外周动脉疾病的旋切术
Cochrane Database Syst Rev. 2014 Mar 17(3):CD006680. doi: 10.1002/14651858.CD006680.pub2.
6
Stent Graft vs Drug-Coated Balloon in Endovascular Treatment of Complex Femoropopliteal Artery Lesions: A 2-Center Experience.支架型人工血管与药物涂层球囊治疗复杂股腘动脉病变的血管内治疗:一项双中心经验
J Endovasc Ther. 2025 Aug;32(4):1038-1046. doi: 10.1177/15266028231201097. Epub 2023 Sep 20.
7
Vessel Preparation in Infrapopliteal Arterial Disease: A Systematic Review and Meta-Analysis.《主-髂动脉疾病腔内治疗中国专家共识》要点 **关键词**:主-髂动脉疾病;腔内治疗;专家共识 **摘要**:目的 对主-髂动脉疾病腔内治疗的中国专家共识进行总结,为临床实践提供指导。方法 采用循证医学的方法,对国内外发表的相关文献进行检索和分析,结合专家的临床经验和意见,制定了共识的推荐意见。结果 共识共包括 23 条推荐意见,涵盖了主-髂动脉疾病的流行病学、诊断、治疗策略、腔内治疗技术、围手术期管理等方面。结论 本共识为中国医生提供了主-髂动脉疾病腔内治疗的规范化建议,有助于提高治疗效果和改善患者预后。
J Endovasc Ther. 2024 Apr;31(2):191-202. doi: 10.1177/15266028221120752. Epub 2022 Sep 4.
8
Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.药物洗脱球囊血管成形术与未涂层球囊血管成形术治疗下肢外周动脉疾病的比较。
Cochrane Database Syst Rev. 2016 Aug 4;2016(8):CD011319. doi: 10.1002/14651858.CD011319.pub2.
9
Covered vs Uncovered Stents for Aortoiliac and Femoropopliteal Arterial Disease: A Systematic Review and Meta-analysis.覆膜支架与非覆膜支架治疗主髂动脉和股腘动脉疾病:一项系统评价和荟萃分析
J Endovasc Ther. 2016 Jun;23(3):442-52. doi: 10.1177/1526602816643834. Epub 2016 Apr 20.
10
Comparative Effectiveness of Endovascular Treatment Modalities for De Novo Femoropopliteal Lesions: A Network Meta-analysis of Randomized Controlled Trials.腔内治疗新发股浅动脉病变的比较效果:一项随机对照试验的网络荟萃分析。
J Endovasc Ther. 2020 Feb;27(1):42-59. doi: 10.1177/1526602819895996.

引用本文的文献

1
Innovative nomogram for predicting 1-year clinically driven revascularization outcomes in endovascular femoropopliteal disease.用于预测血管腔内股腘动脉疾病1年临床驱动血管重建结局的创新列线图。
Front Cardiovasc Med. 2024 Aug 28;11:1438214. doi: 10.3389/fcvm.2024.1438214. eCollection 2024.
2
Trends and Factors Associated With Peripheral Vascular Interventions for the Treatment of Claudication From 2011 to 2022: A National Medicare Cohort Study.2011 年至 2022 年治疗间歇性跛行的外周血管介入治疗的趋势和相关因素:一项全国性医疗保险队列研究。
J Am Heart Assoc. 2024 Jul 16;13(14):e033463. doi: 10.1161/JAHA.123.033463. Epub 2024 Jul 3.
3
Scoping review of atherectomy and intravascular lithotripsy with or without balloon angioplasty in below-the-knee lesions.
对膝下病变采用或不采用球囊血管成形术的旋切术和血管内碎石术的范围综述。
J Vasc Surg Cases Innov Tech. 2023 May 3;9(2):101185. doi: 10.1016/j.jvscit.2023.101185. eCollection 2023 Jun.
4
Directional atherectomy combined with drug-coated balloon angioplasty for superficial femoral arteriosclerosis obliterans.药物涂层球囊血管成形术联合定向斑块旋切术治疗股浅动脉粥样硬化闭塞症。
Ann R Coll Surg Engl. 2023 Sep;105(7):627-631. doi: 10.1308/rcsann.2022.0164. Epub 2023 Mar 16.
5
Excimer laser atherectomy combined with drug-coated balloon angioplasty for the treatment of femoropopliteal arteriosclerosis obliterans.准分子激光斑块消蚀术联合药物涂层球囊血管成形术治疗股腘动脉硬化闭塞症。
Ann R Coll Surg Engl. 2022 Nov;104(9):667-672. doi: 10.1308/rcsann.2021.0335. Epub 2022 Apr 21.
6
Index atherectomy peripheral vascular interventions performed for claudication are associated with more reinterventions than nonatherectomy interventions.索引动脉切除术外周血管介入治疗间歇性跛行与非动脉切除术介入治疗相比,需要更多的再次介入治疗。
J Vasc Surg. 2022 Aug;76(2):489-498.e4. doi: 10.1016/j.jvs.2022.02.034. Epub 2022 Mar 8.
7
Patient doses in endovascular and hybrid revascularization of aortoiliac segment.腹主动脉瘤腔内和杂交重建术中的患者剂量。
Br J Radiol. 2021 Dec;94(1128):20210439. doi: 10.1259/bjr.20210439. Epub 2021 Oct 5.
8
Use of Atherectomy During Index Peripheral Vascular Interventions.在指数外周血管介入治疗中使用旋切术。
JACC Cardiovasc Interv. 2021 Mar 22;14(6):678-688. doi: 10.1016/j.jcin.2021.01.004.
9
Peripheral Vascular Disease in Women: Therapeutic Options in 2019.2019年女性外周血管疾病的治疗选择
Curr Treat Options Cardiovasc Med. 2019 Nov 14;21(11):68. doi: 10.1007/s11936-019-0769-5.
10
Adverse Events After Atherectomy: Analyzing Long-Term Outcomes of Endovascular Lower Extremity Revascularization Techniques.血管腔内下肢血运重建技术治疗后不良事件分析:长期结果
J Am Heart Assoc. 2019 Jun 18;8(12):e012081. doi: 10.1161/JAHA.119.012081. Epub 2019 Jun 5.